Dacarbazine
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Dacarbazine |
| DrugBank ID | DB00851 |
| KG Predictions | 12 |
| DL Predictions (≥0.7) | 0 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 12 knowledge graph predictions and 0 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| classic Hodgkin lymphoma, lymphocyte-rich type | KG |
| metastatic melanoma | KG |
| Hodgkins lymphoma | KG |
| obsolete Hodgkin’s granuloma | KG |
| Hodgkin’s paragranuloma | KG |
| classic Hodgkin lymphoma | KG |
| classic Hodgkin lymphoma, lymphocyte-rich type | KG |
| metastatic melanoma | KG |
| Hodgkins lymphoma | KG |
| obsolete Hodgkin’s granuloma | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB00851
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.